Skip to main content

Table 3 Surgical Outcomes Summary

From: Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital

 Subjects, n (%)
Total failure rate6 (21.4)
Intraocular pressure not ≥20% reduction from baseline3 (10.7)
Secondary surgical intervention3 (10.7)
Postoperative Increase in antiglaucoma medications0 (0.0)
Lost to follow-up prior to postoperative month 12a13 (46.4)
  1. aPatients lost to follow-up were censored in survival analysis